Skip to main content
Premium Trial:

Request an Annual Quote

Dennis Gilbert, Clive Brown

Dennis Gilbert has left his position as chief scientific officer and vice president for research at Applied Biosystems as of Aug. 1, a company spokesman confirmed last week. Gilbert resigned to “pursue other career interests,” said the spokesman, who was unable to provide further information on Gilbert’s plans or whether the company is seeking a replacement.
In addition to his positions as CSO and VP of research, Gilbert managed ABI’s Advanced Research and Technology organization, which is responsible for identifying and developing new technologies and applications.
During his tenure of more than 12 years with ABI, Gilbert held a number of other positions, including vice president of advanced research and technology, vice president of genomics applications, and vice president of gene discovery at ABI’s sister company Celera Genomics.
Prior to joining ABI, he was program manager of genetics at W.R. Grace.
Gilbert holds a BS degree biochemistry and cell biology from the University of California, San Diego, and a PhD in genetics from Johns Hopkins University.

Clive Brown has joined the Wellcome Trust Sanger Institute as a group leader in next-generation sequencing informatics R&D.
Previously, he was director of computational biology and IT at Solexa in Little Chesterford, UK, which he joined in late 2002. He left the company in January prior to the its merger with Illumina.
“When I joined I had a mental target of what I wanted to achieve, and by January 2007, most of that was in place,” he told In Sequence by e-mail this week.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.